Skip to main content
Top
Published in: The Journal of Headache and Pain 4/2008

Open Access 01-08-2008 | Original

Nitric oxide-induced headache may arise from extracerebral arteries as judged from tolerance to isosorbide-5-mononitrate

Authors: Ingelise Christiansen, Helle K. Iversen, Jes Olesen, Peer Tfelt-Hansen

Published in: The Journal of Headache and Pain | Issue 4/2008

Login to get access

Abstract

Long-term exposure to organic nitrates influences different sections of the vascular bed heterogeneously. Continuous dosage of nitrates leads to the development of tolerance both to the vascular effects and to the unwanted adverse effect, headache. Human data on the development of tolerance in different cranial arteries over more than 24 h are lacking. We compared the vascular changes of the middle cerebral, superficial temporal and radial arteries during oral administration of isosorbide-5-mononitrate (5-ISMN) 30 mg three times daily for 7 days in 11 healthy subjects in a double-blind, randomised, placebo controlled cross-over design. Blood velocity in the middle cerebral artery was measured with transcranial Doppler and the diameters of the temporal and radial arteries were measured with high frequency ultrasound. Headache recordings were compared to the observed vascular changes over time. Tolerance was complete within 24 h in the middle cerebral artery whilst in the superficial temporal and the radial arteries, tolerance was only partial and developed much more slowly, i.e. after 7 days correlating with the disappearance of NO-induced headache. The present study thus demonstrated the important differences in the time profiles of appearance of nitrate tolerance in arteries of different vascular beds in man. If vasodilatation is the cause of NO-induced headache the results point to extracerebral arteries as the locus of nociception. Due to a variety of other possible pain-inducing effects of nitric oxide our results do not exclude cerebral arteries.
Literature
1.
go back to reference Ignarro LJ, Lipton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA (1981) Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218: 6115052, 1:CAS:528:DyaL3MXltVymsrg%3D739–749PubMed Ignarro LJ, Lipton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA (1981) Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218: 6115052, 1:CAS:528:DyaL3MXltVymsrg%3D739–749PubMed
2.
go back to reference Moncada S, Higgs EA (1991) Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest 21:361–374, 1718757, 10.1111/j.1365-2362.1991.tb01383.x, 1:CAS:528:DyaK3MXmsFams7k%3DCrossRefPubMed Moncada S, Higgs EA (1991) Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest 21:361–374, 1718757, 10.1111/j.1365-2362.1991.tb01383.x, 1:CAS:528:DyaK3MXmsFams7k%3DCrossRefPubMed
3.
go back to reference Iversen HK, Olesen J (1996) Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia 16:412–418, 8902249, 10.1046/j.1468-2982.1996.1606412.x, 1:STN:280:DyaK2s%2Flsl2iuw%3D%3DCrossRefPubMed Iversen HK, Olesen J (1996) Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia 16:412–418, 8902249, 10.1046/j.1468-2982.1996.1606412.x, 1:STN:280:DyaK2s%2Flsl2iuw%3D%3DCrossRefPubMed
4.
go back to reference Iversen HK, Nielsen TH, Garre K, Tfelt-Hansen P, Olesen J (1992) Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrate. Eur J Clin Pharmacol 42:31–35, 1541314, 10.1007/BF00314916, 1:CAS:528:DyaK38XhvVOksL4%3DCrossRefPubMed Iversen HK, Nielsen TH, Garre K, Tfelt-Hansen P, Olesen J (1992) Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrate. Eur J Clin Pharmacol 42:31–35, 1541314, 10.1007/BF00314916, 1:CAS:528:DyaK38XhvVOksL4%3DCrossRefPubMed
5.
go back to reference Olesen J, Thomsen LL, Iversen HK (1994) Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci 15:149–153, 7538702, 10.1016/0165-6147(94)90075-2, 1:CAS:528:DyaK2cXksl2ltbs%3DCrossRefPubMed Olesen J, Thomsen LL, Iversen HK (1994) Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci 15:149–153, 7538702, 10.1016/0165-6147(94)90075-2, 1:CAS:528:DyaK2cXksl2ltbs%3DCrossRefPubMed
6.
go back to reference Fletcher A, McLoone P, Bulpitt C (1988) Quality of life on angina therapy: a randomized controlled trial of transdermal glyceryl trinitrate against placebo. Lancet 2(8601):4–8, 2898636, 10.1016/S0140-6736(88)92942-X, 1:STN:280:DyaL1c3mtVCqsQ%3D%3DCrossRefPubMed Fletcher A, McLoone P, Bulpitt C (1988) Quality of life on angina therapy: a randomized controlled trial of transdermal glyceryl trinitrate against placebo. Lancet 2(8601):4–8, 2898636, 10.1016/S0140-6736(88)92942-X, 1:STN:280:DyaL1c3mtVCqsQ%3D%3DCrossRefPubMed
7.
go back to reference Christiansen I, Iversen HK, Olesen J (2002) Headache characteristics during the development of tolerance to nitrites. Pathophysiological implications. Cephalalgia 20:437–444, 10.1046/j.1468-2982.2000.00064.xCrossRef Christiansen I, Iversen HK, Olesen J (2002) Headache characteristics during the development of tolerance to nitrites. Pathophysiological implications. Cephalalgia 20:437–444, 10.1046/j.1468-2982.2000.00064.xCrossRef
8.
go back to reference Aaslid R, Markwalder TM, Nomes H (1982) Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 57:769–774, 7143059, 1:STN:280:DyaL3s%2FlvVyqug%3D%3D, 10.3171/jns.1982.57.6.0769CrossRefPubMed Aaslid R, Markwalder TM, Nomes H (1982) Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 57:769–774, 7143059, 1:STN:280:DyaL3s%2FlvVyqug%3D%3D, 10.3171/jns.1982.57.6.0769CrossRefPubMed
9.
go back to reference Thomsen LL, Iversen HK (1993) Experimental and biological variation of three-dimensional transcranial Doppler measurements. J Appl Physiol 75:2805–2810, 7907324, 1:STN:280:DyaK2c7ntFKquw%3D%3DPubMed Thomsen LL, Iversen HK (1993) Experimental and biological variation of three-dimensional transcranial Doppler measurements. J Appl Physiol 75:2805–2810, 7907324, 1:STN:280:DyaK2c7ntFKquw%3D%3DPubMed
10.
go back to reference Nielsen TH, Iversen HK, Tfelt-Hansen P, Olesen J (1993) Small arteries can be accurately studied in-vivo, using high frequency ultrasound. Ultrasound Med Biol 19:717–725, 8134973, 10.1016/0301-5629(93)90089-7, 1:STN:280:DyaK2c7ot1aqsQ%3D%3DCrossRefPubMed Nielsen TH, Iversen HK, Tfelt-Hansen P, Olesen J (1993) Small arteries can be accurately studied in-vivo, using high frequency ultrasound. Ultrasound Med Biol 19:717–725, 8134973, 10.1016/0301-5629(93)90089-7, 1:STN:280:DyaK2c7ot1aqsQ%3D%3DCrossRefPubMed
11.
go back to reference Nielsen TH, Iversen HK, Tfelt-Hansen P (1990) Determination of the luminal diameter of the radial artery in man by high frequency ultrasound: a methodological study. Ultrasound Med Biol 16:789–791, 10.1016/0301-5629(90)90042-BCrossRef Nielsen TH, Iversen HK, Tfelt-Hansen P (1990) Determination of the luminal diameter of the radial artery in man by high frequency ultrasound: a methodological study. Ultrasound Med Biol 16:789–791, 10.1016/0301-5629(90)90042-BCrossRef
12.
go back to reference Matthews JNS, Altman DG, Cambell MJ, Royston P (1990) Analysis of serial measurements in medical research. MBJ 300:230–235, 1:STN:280:DyaK3c7otFKqsg%3D%3DCrossRef Matthews JNS, Altman DG, Cambell MJ, Royston P (1990) Analysis of serial measurements in medical research. MBJ 300:230–235, 1:STN:280:DyaK3c7otFKqsg%3D%3DCrossRef
13.
go back to reference Münzel T, Daiber A, Mülsch A (2005) Explaining the phenomenon of nitrate tolerance. Circ Res 97:618–628, 16195486, 10.1161/01.RES.0000184694.03262.6d, 1:CAS:528:DC%2BD2MXhtVeqsrfICrossRefPubMed Münzel T, Daiber A, Mülsch A (2005) Explaining the phenomenon of nitrate tolerance. Circ Res 97:618–628, 16195486, 10.1161/01.RES.0000184694.03262.6d, 1:CAS:528:DC%2BD2MXhtVeqsrfICrossRefPubMed
14.
go back to reference Taylor T, Chasseaud LF, Major R, Doyle E, Darragh A (1981) Isosorbide 5-mononitrate pharmacokinetics in humans. Biopharm Drug Dispos 2:255–263, 7295882, 10.1002/bdd.2510020306, 1:CAS:528:DyaL3MXlvVSlsr8%3DCrossRefPubMed Taylor T, Chasseaud LF, Major R, Doyle E, Darragh A (1981) Isosorbide 5-mononitrate pharmacokinetics in humans. Biopharm Drug Dispos 2:255–263, 7295882, 10.1002/bdd.2510020306, 1:CAS:528:DyaL3MXlvVSlsr8%3DCrossRefPubMed
15.
go back to reference Major RM, Taylor T, Chasseaud LF, Darragh A, Lambe RF (1984) Isosorbide 5-mononitrate kinetics. Clin Pharmacol Ther 35:653–659, 6713775, 1:CAS:528:DyaL2cXktFKktr8%3DCrossRefPubMed Major RM, Taylor T, Chasseaud LF, Darragh A, Lambe RF (1984) Isosorbide 5-mononitrate kinetics. Clin Pharmacol Ther 35:653–659, 6713775, 1:CAS:528:DyaL2cXktFKktr8%3DCrossRefPubMed
16.
go back to reference Wagner F, Siefert F, Trenk D, Jänchen E (1990) Relationship between pharmacokinetics and hemodynamic tolerance to isosorbide-5-mononitrate. Eur J Clin Pharmacol 38(Suppl 1):S53–S59, 2354713, 10.1007/BF01417565, 1:CAS:528:DyaK3cXkslSqtb8%3DCrossRefPubMed Wagner F, Siefert F, Trenk D, Jänchen E (1990) Relationship between pharmacokinetics and hemodynamic tolerance to isosorbide-5-mononitrate. Eur J Clin Pharmacol 38(Suppl 1):S53–S59, 2354713, 10.1007/BF01417565, 1:CAS:528:DyaK3cXkslSqtb8%3DCrossRefPubMed
17.
go back to reference Dahl A, Russell D, Nyberg-Hansen R, Rootwell K (1989) Effect of nitroglycerin on cerebral circulation measured by transcranial Doppler and SPECT. Stroke 20:173–176CrossRef Dahl A, Russell D, Nyberg-Hansen R, Rootwell K (1989) Effect of nitroglycerin on cerebral circulation measured by transcranial Doppler and SPECT. Stroke 20:173–176CrossRef
18.
go back to reference Iversen HK, Friberg L, Holm S, Tfelt-hansen P (2008) Intracranial hemodynamics during intravenous infusion of nitroglycerin. J Headache Pain (in press) Iversen HK, Friberg L, Holm S, Tfelt-hansen P (2008) Intracranial hemodynamics during intravenous infusion of nitroglycerin. J Headache Pain (in press)
19.
go back to reference White RP, Deane C, Hindley C, Bloomfield PM, Cunningham VJ, Vallance P et al (2000) The effect of the nitric oxide donor glyceryl trinitrate on global and regional cerebral blood flow in man. J Neurol Sci 178:23–28, 11018245, 10.1016/S0022-510X(00)00357-9, 1:CAS:528:DC%2BD3cXmslyjtbw%3DCrossRefPubMed White RP, Deane C, Hindley C, Bloomfield PM, Cunningham VJ, Vallance P et al (2000) The effect of the nitric oxide donor glyceryl trinitrate on global and regional cerebral blood flow in man. J Neurol Sci 178:23–28, 11018245, 10.1016/S0022-510X(00)00357-9, 1:CAS:528:DC%2BD3cXmslyjtbw%3DCrossRefPubMed
20.
go back to reference Bednarczyk EM, Wack DS, Kassab MY, Burch K, Trinidad K, Haka M, Gona J (2002) Brain blood flow in the nitroglycerin (GTN) model of migraine: measurement using positron emision tomography and transcranial Doppler. Cephalalgia 22:749–757, 12421161, 10.1046/j.1468-2982.2002.00440.x, 1:STN:280:DC%2BD38jgtVansQ%3D%3DCrossRefPubMed Bednarczyk EM, Wack DS, Kassab MY, Burch K, Trinidad K, Haka M, Gona J (2002) Brain blood flow in the nitroglycerin (GTN) model of migraine: measurement using positron emision tomography and transcranial Doppler. Cephalalgia 22:749–757, 12421161, 10.1046/j.1468-2982.2002.00440.x, 1:STN:280:DC%2BD38jgtVansQ%3D%3DCrossRefPubMed
21.
go back to reference Friberg L, Olesen J, Iversen HK, Sperling B (1991) Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet 338:13–17, 1676084, 10.1016/0140-6736(91)90005-A, 1:STN:280:DyaK3M3nvVGqug%3D%3DCrossRefPubMed Friberg L, Olesen J, Iversen HK, Sperling B (1991) Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet 338:13–17, 1676084, 10.1016/0140-6736(91)90005-A, 1:STN:280:DyaK3M3nvVGqug%3D%3DCrossRefPubMed
22.
go back to reference Thomsen LL, Iversen HK, Brinck TA, Olesen J (1993) Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers. Cephalalgia 13:395–399, 7906202, 10.1046/j.1468-2982.1993.1306395.x, 1:STN:280:DyaK2c7kslCrtQ%3D%3DCrossRefPubMed Thomsen LL, Iversen HK, Brinck TA, Olesen J (1993) Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers. Cephalalgia 13:395–399, 7906202, 10.1046/j.1468-2982.1993.1306395.x, 1:STN:280:DyaK2c7kslCrtQ%3D%3DCrossRefPubMed
23.
go back to reference Schmetterer L, Woltz M, Krejcy K, Graselli U, Findl O, Eichler HG, Singer EA (1996) Cerebral and ocular hemodynamic effects of sumatriptan in the nitroglycerin headache model. Clin Pharmacol Ther 60:199–205, 8823238, 10.1016/S0009-9236(96)90136-8, 1:CAS:528:DyaK28XmsFSkt7o%3DCrossRefPubMed Schmetterer L, Woltz M, Krejcy K, Graselli U, Findl O, Eichler HG, Singer EA (1996) Cerebral and ocular hemodynamic effects of sumatriptan in the nitroglycerin headache model. Clin Pharmacol Ther 60:199–205, 8823238, 10.1016/S0009-9236(96)90136-8, 1:CAS:528:DyaK28XmsFSkt7o%3DCrossRefPubMed
24.
go back to reference Jurt U, Gori T, Ravandi A, Babaei S, Zeman P, Parker JD (2001) Differential effects of pentaerythritol tetranitrate and nitroglycerin on the delopment of tolerance and evidence: a human in vivo study. J Am Coll Cardiol 38:854–859, 11527645, 10.1016/S0735-1097(01)01414-0, 1:CAS:528:DC%2BD3MXntlaitb0%3DCrossRefPubMed Jurt U, Gori T, Ravandi A, Babaei S, Zeman P, Parker JD (2001) Differential effects of pentaerythritol tetranitrate and nitroglycerin on the delopment of tolerance and evidence: a human in vivo study. J Am Coll Cardiol 38:854–859, 11527645, 10.1016/S0735-1097(01)01414-0, 1:CAS:528:DC%2BD3MXntlaitb0%3DCrossRefPubMed
25.
go back to reference Iversen HK, Nielsen TH, Tfelt-Hansen P, Olesen J (1993) Lack of tolerance of headache and radial artery diameter during a 7 hour intravenous infusion of nitroglycerin. Eur J Clin Pharmacol 44:47–50, 8436154, 10.1007/BF00315279, 1:CAS:528:DyaK3sXit1Ghtrk%3DCrossRefPubMed Iversen HK, Nielsen TH, Tfelt-Hansen P, Olesen J (1993) Lack of tolerance of headache and radial artery diameter during a 7 hour intravenous infusion of nitroglycerin. Eur J Clin Pharmacol 44:47–50, 8436154, 10.1007/BF00315279, 1:CAS:528:DyaK3sXit1Ghtrk%3DCrossRefPubMed
26.
go back to reference Boesgaard S, Iversen H, Wroblewski H, Poulsen HE, Frandsen H, Kastrup J, Aldershvile J (1994) Altered peripheral vasodilatory profile of nitroglycerin during long-term infusion of N-acetylcystein. J Am Coll Cardiol 23:163–169, 8277075, 1:CAS:528:DyaK2cXlslSitro%3D, 10.1016/0735-1097(94)90515-0CrossRefPubMed Boesgaard S, Iversen H, Wroblewski H, Poulsen HE, Frandsen H, Kastrup J, Aldershvile J (1994) Altered peripheral vasodilatory profile of nitroglycerin during long-term infusion of N-acetylcystein. J Am Coll Cardiol 23:163–169, 8277075, 1:CAS:528:DyaK2cXlslSitro%3D, 10.1016/0735-1097(94)90515-0CrossRefPubMed
27.
go back to reference Jeserich M, Münzel T, Pape L, Fischer C, Drexler H, Just H (1995) Absence of vascular tolerance in conductance vessels after 48 hours of intravenous nitroglycerin in patients with coronary artery disease. J Am Coll Cardiol 26:50–56, 7797775, 10.1016/0735-1097(95)00155-S, 1:STN:280:DyaK2MzhvVersQ%3D%3DCrossRefPubMed Jeserich M, Münzel T, Pape L, Fischer C, Drexler H, Just H (1995) Absence of vascular tolerance in conductance vessels after 48 hours of intravenous nitroglycerin in patients with coronary artery disease. J Am Coll Cardiol 26:50–56, 7797775, 10.1016/0735-1097(95)00155-S, 1:STN:280:DyaK2MzhvVersQ%3D%3DCrossRefPubMed
28.
go back to reference Zhang LM, Castresana MR, Newman WH (1994) Tolerance to nitroglycerin in vascular smooth muscle cells: recovery and cross-tolerance to sodium nitroprusside. Anesth Analg 78:1053–1059, 8198258, 10.1213/00000539-199406000-00004, 1:CAS:528:DyaK2cXlvFGgtbg%3DCrossRefPubMed Zhang LM, Castresana MR, Newman WH (1994) Tolerance to nitroglycerin in vascular smooth muscle cells: recovery and cross-tolerance to sodium nitroprusside. Anesth Analg 78:1053–1059, 8198258, 10.1213/00000539-199406000-00004, 1:CAS:528:DyaK2cXlvFGgtbg%3DCrossRefPubMed
29.
go back to reference Tao H, Zhang LM, Castresana MR, Newman WH, Shillcutt SD (1997) Response of cultured cerebral artery smooth muscle cells to the nitric oxide vasodilator, nitroglycerin and sodium nitroprusside. J Neurosurg Anesth 1:58–64, 10.1097/00008506-199701000-00013CrossRef Tao H, Zhang LM, Castresana MR, Newman WH, Shillcutt SD (1997) Response of cultured cerebral artery smooth muscle cells to the nitric oxide vasodilator, nitroglycerin and sodium nitroprusside. J Neurosurg Anesth 1:58–64, 10.1097/00008506-199701000-00013CrossRef
30.
go back to reference Elkayam U (1991) Tolerance to organic nitrates: evidence, mechanisms, clinical relevance and strategies for prevention. Ann Int Med 114:667–677, 2003715, 1:STN:280:DyaK3M7ms1Wksg%3D%3DCrossRefPubMed Elkayam U (1991) Tolerance to organic nitrates: evidence, mechanisms, clinical relevance and strategies for prevention. Ann Int Med 114:667–677, 2003715, 1:STN:280:DyaK3M7ms1Wksg%3D%3DCrossRefPubMed
31.
go back to reference Münzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG (1995) Evidence for enhanced vascular superoxide anion production in nitrate tolerance: a novel mechanism of tolerance and cross tolerance. J Clin Invest 95:187–194, 7814613, 10.1172/JCI117637PubMedCentralCrossRefPubMed Münzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG (1995) Evidence for enhanced vascular superoxide anion production in nitrate tolerance: a novel mechanism of tolerance and cross tolerance. J Clin Invest 95:187–194, 7814613, 10.1172/JCI117637PubMedCentralCrossRefPubMed
32.
go back to reference Münzel T, Giaid A, Kurz S, Stewart D, Harrison D (1995) Evidence for a role of endothelin-1 and protein kinase C in nitrate tolerance. Proc Natl Acad Sci USA 92:5244–5248, 7539147, 10.1073/pnas.92.11.5244PubMedCentralCrossRefPubMed Münzel T, Giaid A, Kurz S, Stewart D, Harrison D (1995) Evidence for a role of endothelin-1 and protein kinase C in nitrate tolerance. Proc Natl Acad Sci USA 92:5244–5248, 7539147, 10.1073/pnas.92.11.5244PubMedCentralCrossRefPubMed
33.
go back to reference Szöcs K, Lasseque B, Wenzel P, Wendt M, Daiber A, Oelze M, Meinertz T, Münzel T, Baldus S (2007) Increased superoxide production in nitrate tolerance is associated with NAD(P) H oxidase and aldehyde dehydrogenase 2 downregulation. J Mol Cell Cardiol 42:1111–1118, 17493633, 10.1016/j.yjmcc.2007.03.904, 1:CAS:528:DC%2BD2sXmtVeitrw%3DCrossRefPubMed Szöcs K, Lasseque B, Wenzel P, Wendt M, Daiber A, Oelze M, Meinertz T, Münzel T, Baldus S (2007) Increased superoxide production in nitrate tolerance is associated with NAD(P) H oxidase and aldehyde dehydrogenase 2 downregulation. J Mol Cell Cardiol 42:1111–1118, 17493633, 10.1016/j.yjmcc.2007.03.904, 1:CAS:528:DC%2BD2sXmtVeitrw%3DCrossRefPubMed
34.
go back to reference Parker JD, Farrell B, Fenton T, Cohanim M, Parker JO (1991) Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation 84:2336–2345, 1835676, 1:CAS:528:DyaK38XpvFSmtw%3D%3DCrossRefPubMed Parker JD, Farrell B, Fenton T, Cohanim M, Parker JO (1991) Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation 84:2336–2345, 1835676, 1:CAS:528:DyaK38XpvFSmtw%3D%3DCrossRefPubMed
35.
go back to reference Chen YR, Nie SD, Shan W, Jiang DJ, Shi RZ, Zhou Z et al (2007) Decrease in endogenous CGRP release in nitroglycerin tolerance: role of ALDH-2. Eur J Pharmacol 571:44–50, 17585900, 10.1016/j.ejphar.2007.05.042, 1:CAS:528:DC%2BD2sXpsFKgu74%3DCrossRefPubMed Chen YR, Nie SD, Shan W, Jiang DJ, Shi RZ, Zhou Z et al (2007) Decrease in endogenous CGRP release in nitroglycerin tolerance: role of ALDH-2. Eur J Pharmacol 571:44–50, 17585900, 10.1016/j.ejphar.2007.05.042, 1:CAS:528:DC%2BD2sXpsFKgu74%3DCrossRefPubMed
36.
go back to reference Daiber A, Oelze M, Coldeway M, Bachsmid M, Wenzel P, Sydow K et al (2004) Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol with other organic nitrates. Mol Pharmacol 66:1372–1382, 15331769, 10.1124/mol.104.002600, 1:CAS:528:DC%2BD2cXhtVOit73KCrossRefPubMed Daiber A, Oelze M, Coldeway M, Bachsmid M, Wenzel P, Sydow K et al (2004) Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol with other organic nitrates. Mol Pharmacol 66:1372–1382, 15331769, 10.1124/mol.104.002600, 1:CAS:528:DC%2BD2cXhtVOit73KCrossRefPubMed
37.
go back to reference Sydow K, Daiber A, Oelze M, Chen Z, August M, Wendt M et al (2004) Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest 113:482–489, 14755345, 1:CAS:528:DC%2BD2cXhtFSlsLw%3DPubMedCentralCrossRefPubMed Sydow K, Daiber A, Oelze M, Chen Z, August M, Wendt M et al (2004) Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest 113:482–489, 14755345, 1:CAS:528:DC%2BD2cXhtFSlsLw%3DPubMedCentralCrossRefPubMed
38.
go back to reference Hink U, Daiber A, Kayhan N, Trischler J, Kattz C, Oelze M et al (2007) Oxidative inhibition of mitochondrial aldehyde dehydrogenase promotes nitroglycerin tolerance in human blood vessels. J Am Coll Cardiol 50:2226–2232, 18061070, 10.1016/j.jacc.2007.08.031, 1:CAS:528:DC%2BD2sXhsVSgur%2FECrossRefPubMed Hink U, Daiber A, Kayhan N, Trischler J, Kattz C, Oelze M et al (2007) Oxidative inhibition of mitochondrial aldehyde dehydrogenase promotes nitroglycerin tolerance in human blood vessels. J Am Coll Cardiol 50:2226–2232, 18061070, 10.1016/j.jacc.2007.08.031, 1:CAS:528:DC%2BD2sXhsVSgur%2FECrossRefPubMed
39.
go back to reference Schoonman GG, Bakker D, Schmitz N, van der Geest RJ, van der Grond J, Ferrari MD, van Buchem MA (2006) Magnetic resonance angiography of the human meningeal artery: implications for migraine. J Magn Reson Imaging 24:918–921, 16958062, 10.1002/jmri.20708CrossRefPubMed Schoonman GG, Bakker D, Schmitz N, van der Geest RJ, van der Grond J, Ferrari MD, van Buchem MA (2006) Magnetic resonance angiography of the human meningeal artery: implications for migraine. J Magn Reson Imaging 24:918–921, 16958062, 10.1002/jmri.20708CrossRefPubMed
40.
go back to reference Kruuse C, Thomsen LL, Birk S, Olesen J (2003) Migraine can be induced by sildefanil without changes in middle cerebral artery diameter. Brain 126:241–247, 12477710, 10.1093/brain/awg009CrossRefPubMed Kruuse C, Thomsen LL, Birk S, Olesen J (2003) Migraine can be induced by sildefanil without changes in middle cerebral artery diameter. Brain 126:241–247, 12477710, 10.1093/brain/awg009CrossRefPubMed
Metadata
Title
Nitric oxide-induced headache may arise from extracerebral arteries as judged from tolerance to isosorbide-5-mononitrate
Authors
Ingelise Christiansen
Helle K. Iversen
Jes Olesen
Peer Tfelt-Hansen
Publication date
01-08-2008
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue 4/2008
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1007/s10194-008-0043-9

Other articles of this Issue 4/2008

The Journal of Headache and Pain 4/2008 Go to the issue